– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer – – Featured key opinion leaders include Dr. Maurizio Fava, M.D., Massachusetts General Hospital and Harvard Medical School; and Dr. Gitte Moos Knudsen, Professor, Chief Neurologist, DMSc, Neurobiology Research Unit, Rigshospitalet and University of Copenhagen, Denmark…
Ionis, Otsuka sign agreement for hereditary angioedema therapy
Share this article Ionis will be responsible for the non-clinical and clinical development of the product. Credit: Mongkolchon Akesin / Shutterstock.com. Ionis Pharmaceuticals has signed